# Open Deep Research Team - Example Workflow

## Example Research Request

**User Query:** "I need comprehensive research on the current state and future of quantum computing in drug discovery, including technical implementations, academic research, market analysis, and practical applications."

## Workflow Execution

### Phase 1: Query Processing

#### Step 1.1: Orchestrator Initialization
```json
{
  "action": "initialize_research",
  "query": "quantum computing in drug discovery",
  "timestamp": "2024-01-15T10:00:00Z",
  "project_id": "QC-DD-001",
  "depth": "comprehensive"
}
```

#### Step 1.2: Query Clarification
```json
{
  "agent": "query_clarifier",
  "analysis": {
    "clarity_score": 0.75,
    "issues": ["Time frame not specified", "Geographic scope unclear"],
    "clarification_needed": true
  },
  "questions": [
    {
      "question": "What time frame should the research cover?",
      "options": [
        "Current state only (2023-2024)",
        "Near future (2024-2026)",
        "Long-term outlook (2024-2030)",
        "Historical development + future"
      ]
    },
    {
      "question": "Geographic or market focus?",
      "options": [
        "Global perspective",
        "North America focus",
        "Specific country/region",
        "Comparative analysis across regions"
      ]
    }
  ]
}
```

**User Response:** "Focus on current state and near future (2024-2026), global perspective"

#### Step 1.3: Research Brief Generation
```json
{
  "agent": "research_brief_generator",
  "brief": {
    "title": "Quantum Computing Applications in Drug Discovery: Current State and Near-Future Outlook",
    "primary_questions": [
      "What quantum computing approaches are currently being used in drug discovery?",
      "Which pharmaceutical companies are investing in quantum computing?",
      "What are the technical limitations and how are they being addressed?",
      "What breakthroughs are expected by 2026?"
    ],
    "scope": {
      "temporal": "2023-2026",
      "geographic": "Global",
      "sectors": ["Pharmaceuticals", "Biotech", "Quantum Computing"],
      "depth": "Technical and business analysis"
    },
    "success_criteria": [
      "Identify at least 10 active implementations",
      "analyze 3+ technical approaches",
      "Assess market size and growth",
      "Provide actionable insights for stakeholders"
    ]
  }
}
```

### Phase 2: Research Planning

#### Step 2.1: Research Coordination
```json
{
  "agent": "research_coordinator",
  "strategy": "hybrid_parallel_sequential",
  "task_allocation": {
    "phase_1_parallel": {
      "academic_researcher": {
        "tasks": [
          "Review quantum algorithms for molecular simulation",
          "Analyze protein folding applications",
          "Survey computational chemistry advances"
        ],
        "duration": "30_minutes"
      },
      "technical_researcher": {
        "tasks": [
          "Analyze IBM Qiskit implementations",
          "Review Google Quantum AI drug discovery projects",
          "Evaluate Microsoft Azure Quantum solutions"
        ],
        "duration": "25_minutes"
      },
      "data_analyst": {
        "tasks": [
          "Market size analysis for quantum computing in pharma",
          "Investment trends 2020-2024",
          "Company participation metrics"
        ],
        "duration": "20_minutes"
      }
    },
    "phase_2_synthesis": {
      "research_synthesizer": {
        "inputs": ["academic_findings", "technical_analysis", "market_data"],
        "duration": "15_minutes"
      }
    }
  }
}
```

### Phase 3: Parallel Research Execution

#### Step 3.1: Academic Research Results
```json
{
  "agent": "academic_researcher",
  "findings": {
    "papers_reviewed": 47,
    "key_algorithms": [
      {
        "name": "Variational Quantum Eigensolver (VQE)",
        "applications": "Molecular ground state calculation",
        "citations": 1250,
        "maturity": "experimental"
      },
      {
        "name": "Quantum Approximate Optimization Algorithm (QAOA)",
        "applications": "Protein folding optimization",
        "citations": 890,
        "maturity": "theoretical"
      }
    ],
    "research_groups": [
      "MIT-Harvard Quantum Initiative",
      "Oxford Quantum Computing",
      "Toronto Vector Institute"
    ],
    "breakthrough_papers": [
      {
        "title": "Quantum advantage in drug-target interaction prediction",
        "journal": "Nature Computational Science",
        "year": 2023,
        "impact": "Demonstrated 100x speedup for specific molecular simulations"
      }
    ]
  }
}
```

#### Step 3.2: Technical Research Results
```json
{
  "agent": "technical_researcher",
  "findings": {
    "implementations": [
      {
        "company": "IBM",
        "platform": "Qiskit Runtime",
        "drug_discovery_tools": ["Protein folding service", "Molecular dynamics"],
        "github_stars": 3400,
        "production_ready": false
      },
      {
        "company": "Menten AI & IBM",
        "platform": "Hybrid classical-quantum",
        "drug_discovery_tools": ["Drug-target interaction"],
        "status": "Pilot phase",
        "results": "15% improvement in prediction accuracy"
      }
    ],
    "technical_challenges": [
      "Quantum decoherence limiting computation time",
      "Limited qubit count (current max ~1000 qubits)",
      "Error rates requiring extensive correction"
    ],
    "code_examples": [
      {
        "purpose": "Molecular simulation",
        "language": "Python",
        "framework": "Qiskit",
        "complexity": "intermediate"
      }
    ]
  }
}
```

#### Step 3.3: Data Analysis Results
```json
{
  "agent": "data_analyst",
  "findings": {
    "market_metrics": {
      "current_market_size": "$145M (2023)",
      "projected_size_2026": "$850M",
      "cagr": "82%",
      "key_investors": [
        {"company": "Roche", "investment": "$60M"},
        {"company": "Merck", "investment": "$45M"},
        {"company": "Johnson & Johnson", "investment": "$30M"}
      ]
    },
    "adoption_metrics": {
      "companies_using": 23,
      "pilot_projects": 67,
      "production_deployments": 0,
      "expected_production_2026": 8
    },
    "roi_analysis": {
      "drug_discovery_time_reduction": "Projected 30-40%",
      "cost_savings": "$100M-500M per successful drug",
      "break_even": "2027-2028 for early adopters"
    }
  }
}
```

### Phase 4: Synthesis

#### Step 4.1: Research Synthesis
```json
{
  "agent": "research_synthesizer",
  "synthesis": {
    "convergent_findings": [
      "Quantum computing shows promise but not yet production-ready",
      "2025-2026 expected breakthrough period",
      "Hybrid classical-quantum approaches most practical"
    ],
    "divergent_findings": [
      {
        "topic": "Timeline to practical advantage",
        "academic_view": "5-7 years",
        "industry_view": "2-3 years",
        "synthesis": "Depends on specific use case and error tolerance"
      }
    ],
    "key_patterns": [
      "Focus shifting from pure quantum to hybrid approaches",
      "Investment accelerating despite technical challenges",
      "Partnerships between quantum and pharma companies increasing"
    ],
    "confidence_assessment": {
      "technical_feasibility": 0.75,
      "market_projections": 0.82,
      "timeline_estimates": 0.65
    }
  }
}
```

### Phase 5: Report Generation

#### Step 5.1: Final Report Structure
```markdown
# Quantum Computing in Drug Discovery: Comprehensive Analysis 2024-2026

## Executive Summary
- Quantum computing poised to revolutionize drug discovery but faces technical hurdles
- Market expected to grow from $145M to $850M by 2026 (82% CAGR)
- Hybrid classical-quantum approaches showing most immediate promise
- First production deployments expected 2025-2026

## 1. Current State of Technology
### 1.1 Active Implementations
[Detailed analysis of 10+ implementations]

### 1.2 Technical Approaches
- Variational Quantum Eigensolver (VQE) for molecular simulation
- QAOA for optimization problems
- Quantum machine learning for drug-target interaction

## 2. Market Analysis
### 2.1 Investment Landscape
[Charts and data on $180M+ investments]

### 2.2 Company Participation
[Analysis of 23 active companies]

## 3. Technical Challenges and Solutions
### 3.1 Current Limitations
- Qubit coherence times: ~100 microseconds
- Error rates: 0.1-1%
- Qubit count: Max ~1000

### 3.2 Breakthrough Technologies
[Analysis of error correction, new architectures]

## 4. Case Studies
### 4.1 IBM-Pfizer Collaboration
### 4.2 Google-Boehringer Ingelheim Partnership
### 4.3 Microsoft Azure Quantum Platform

## 5. Future Outlook 2024-2026
### 5.1 Expected Milestones
- 2024: First validated quantum advantage in specific drug discovery task
- 2025: Hybrid systems in production pilot
- 2026: 3-5 production deployments

## 6. Recommendations
1. **For Pharmaceutical Companies**: Begin pilot projects with hybrid approaches
2. **For Investors**: Focus on companies with strong classical-quantum integration
3. **For Researchers**: Prioritize error correction and algorithm optimization

## References
[47 academic papers, 15 technical reports, 12 market analyses]
```

## Quality Metrics

### Research Quality Assessment
```json
{
  "coverage_metrics": {
    "questions_answered": "100%",
    "source_diversity": "High (academic, technical, business)",
    "geographic_coverage": "Global (US, EU, Asia)",
    "time_relevance": "95% sources from 2023-2024"
  },
  "confidence_scores": {
    "overall": 0.84,
    "technical_accuracy": 0.89,
    "market_projections": 0.78,
    "timeline_reliability": 0.71
  },
  "limitations_noted": [
    "Rapid field evolution may outdate findings",
    "Limited production data available",
    "Proprietary implementations not fully accessible"
  ]
}
```

## Time and Resource Utilization

### Execution Timeline
- Query Processing: 5 minutes
- Research Planning: 3 minutes
- Parallel Research: 30 minutes
- Synthesis: 15 minutes
- Report Generation: 10 minutes
- **Total Time**: 63 minutes

### Resource Usage
- Academic databases accessed: 5
- Repositories analyzed: 12
- Market reports reviewed: 8
- Total sources consulted: 89
- Final citations: 74

## Outcome

The research successfully provided:
1. Comprehensive overview of quantum computing in drug discovery
2. Technical implementation details with code examples
3. Market analysis with investment data
4. Practical recommendations for stakeholders
5. Clear timeline and milestone projections
6. Balanced view of opportunities and challenges

This example demonstrates the full capability of the Open Deep Research Team in handling complex, multifaceted research requests efficiently and thoroughly.
